Esophageal Dilation denied as not FDA-approved for this use by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for esophageal dilation are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied Esophageal Dilation as "Not FDA-Approved"

Esophageal dilation is a well-established endoscopic procedure used to treat strictures, rings, and narrowing of the esophagus that cause difficulty swallowing. BCBS occasionally issues "not FDA-approved" denials when the specific device or balloon catheter used falls outside the exact FDA clearance language documented in the claim, or when the procedure is coded in a way that triggers an automated review flag. This is almost always a coverage determination error — esophageal dilation instruments have FDA 510(k) clearances, and the procedure itself has decades of published clinical and gastroenterology society support.

## Why This Denial Is Appealable

The denial likely reflects a coding mismatch or a plan policy exclusion applied in error. You are entitled to a full appeal under your plan's internal grievance process and, if that fails, an independent external review under ACA §2719 (for non-grandfathered plans) or ERISA §503 (for employer-sponsored plans). External review must typically be requested within approximately four months of a final internal denial. An expedited review is available when your condition is urgent.

## Your Appeal Timeline

1. Request the denial letter and the plan's operative medical/coverage policy in writing. 2. File a first-level internal appeal — deadlines are printed on your Explanation of Benefits. 3. If upheld, file a second-level internal appeal (if your plan offers one). 4. Request independent external review within the window stated on the final denial.

## Documentation to Gather

• Diagnosis confirmation: Endoscopy or imaging reports establishing the esophageal stricture or dysphagia diagnosis, with ICD codes.
• Clinical severity: Physician notes documenting frequency, severity, and functional impact of swallowing difficulty.
• Device/procedure records: Operative report confirming the specific dilation device used and its FDA clearance or 510(k) number — your endoscopist's billing team can supply this.
• Prior treatment history: Notes on any prior dilations and outcomes, or conservative measures attempted.
• Prescriber medical-necessity letter: A letter from your gastroenterologist or surgeon stating the procedure is medically necessary, consistent with applicable society guidelines (e.g., ACG or ASGE), and that the device used holds appropriate FDA clearance.

## Criteria-Mapping Structure

Request BCBS's published coverage policy for esophageal dilation. Then, side by side:

| Policy Requirement | Your Chart Evidence | |---|---| | Diagnosis covered by policy | Cite your endoscopy/imaging report | | Device has FDA clearance | Cite 510(k) number from operative note | | Procedure performed by qualified provider | Cite provider credentials | | Medical necessity documented | Cite prescriber letter and clinical notes |

A clear table mapping every policy criterion to a specific dated chart entry is the most persuasive element in an esophageal dilation appeal.